IP Library Granted Patent US 8,071,135
Granted Patent B2
US 8,071,135 · App. 11/973,125 · Granted Dec 6, 2011

Placental tissue compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,071,135
App. No.
11/973,125
Granted
Dec 6, 2011
Kind
B2
Abstract

The present invention encompasses compositions, including solutions, gels, and pastes, manufactured from amniotic membrane, umbilical cord membrane, or both. The present invention also encompasses methods of making such compositions, and methods of using the compositions to treat conditions of the eye.

Claims (23)

1. A composition comprising placental tissue components soluble in aqueous solution at acidic and neutral pH, and substantially lacking placental tissue components insoluble in aqueous solution at acidic and neutral pH, wherein the composition is prepared according to the following method:

(a) contacting placental tissue with an acidic solution;

(b) bringing the solution to neutral pH; and

(c) removing insoluble matter within said solution to form the composition.

2. The composition of claim 1 , wherein said placental tissue is amniotic membrane (AM).

3. The composition of claim 1 , wherein the composition is formulated as a liquid, gel, paste, slurry, cream or ointment.

4. The composition of claim 3 , wherein the composition is an ophthalmologically-acceptable liquid.

5. The composition of claim 4 , wherein said liquid comprises saline solution, glycerin, hypromellose, or polyethylene glycol.

6. The composition of claim 1 comprising at least 10% placental components by weight.

7. The composition of claim 1 , wherein the composition is formulated as a lyophilized composition.

8. The composition of claim 1 further comprising an ophthalmologically-acceptable lubricant.

9. The composition of claim 1 further comprising one or more of an anti-inflammatory compound, an analgesic, an anesthetic or an immune-suppressing agent.

10. The composition of claim 1 further comprising riboflavin.

11. The composition of claim 10 , wherein the composition comprises collagen crosslinked with the riboflavin.

12. The composition of claim 1 , wherein the insoluble matter in said solution is removed following step (a).

13. The composition of claim 12 , wherein the method further comprises removal of the insoluble matter in said solution following step (b).

14. The composition of claim 1 , wherein the placental tissue is substantially bloodless.

15. The composition of claim 1 , wherein said acidic solution is an acetic acid solution.

16. The composition of claim 1 , wherein said acidic solution is between about pH 4.5 and about pH 6.

17. The composition of claim 1 , wherein said placental tissue is disrupted at a temperature of between about the freezing point of said solution to about 10° C.

18. The composition of claim 17 comprising decellularizing said placental tissue prior to said disruption.

19. The composition of claim 1 , additionally comprising adjusting the water content of the solution to no greater than about 50%.

20. The composition of claim 1 , wherein the insoluble matter is removed by centrifugation.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 30, 2025
From: CELULARITY INC.
To: CELENIV PTE. LTD.
Reel/Frame 073705/0109 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2017
From: CELULARITY BIOSOURCING, LLC
To: CELULARITY, INC.
Reel/Frame 044098/0717 →
CHANGE OF NAME Recorded Nov 9, 2017
From: HLI CELLULAR THERAPEUTICS, LLC
To: CELULARITY BIOSOURCING, LLC
Reel/Frame 044707/0351 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2016
From: ANTHROGENESIS CORPORATION, A NEW JERSEY CORPORATION, D/B/A CELGENE CELLULAR THERAPEUTICS
To: HLI CELLULAR THERAPEUTICS, LLC, A DELAWARE LIMITED LIABILITY COMPANY
Reel/Frame 039411/0443 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2010
From: LIU, QING; RAY, CYNTHIA
To: ANTHROGENESIS CORPORATION
Reel/Frame 025121/0371 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2010
From: LIU, QING; RAY, CYNTHIA
To: ANTHROGENESIS CORPORATION
Reel/Frame 025071/0309 →